SCHEMBL5529232

SCHEMBL5529232

NS(=O)(=O)Nc1ccc(-c2ccc(C(F)(F)F)cc2)cc1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 18/20 1.00
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
PTGES2 Q9H7Z7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659840 0.85 KIF11 (0.74) KIF11
SCHEMBL4400160 0.85 KIF11 (1.00) KIF11CA1CA2PTGES2
SCHEMBL5528573 0.85 KIF11 (0.74) KIF11
SCHEMBL5531430 0.85 KIF11 (1.00) KIF11CA1CA2PTGES2
SCHEMBL5520999 0.84 KIF11 (1.00) KIF11CA1CA2PTGES2
SCHEMBL5527241 0.84 KIF11 (1.00) KIF11CA1CA2PTGES2
SCHEMBL5524429 0.83 KIF11 (1.00) KIF11CA1CA2
SCHEMBL5530993 0.82 KIF11 (1.00) KIF11CA1CA2PTGES2
SCHEMBL5527574 0.82 KIF11 (0.70) KIF11CA1CA2
SCHEMBL5527580 0.81 KIF11 (0.68) KIF11CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142460-A1 Compounds, compositions and methods CYTOKINETICS, INCORPORATED 2007-06-21 US claimed
US-20070142460-A1 Compounds, compositions and methods CYTOKINETICS, INCORPORATED 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142460-A1 Compounds, compositions and methods ALPP, PCNA, MKI67 KIF11 824/4885CA1 2205/4885CA2 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.